Amphastar Pharmaceuticals Inc (NAS:AMPH)
$ 21.48 +0.47 (+2.21%) Market Cap: 947.12 Mil Enterprise Value: 1.34 Bil PE Ratio: 12.94 PB Ratio: 1.24 GF Score: 83/100

Amphastar Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 10:15 PM GMT
Release Date Price: $27.76 (-3.98%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AMPH.OQ - Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc at JPMorgan Healthcare Conference
Jan 14, 2026 / 10:15PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello everybody. I'm Ekaterinaiskova from JPMorgan. I'm pleased to be introducing AMAStar. And from AMAStar, we have Jack Zhang, CEO, and Bill Peters, CFO, who will be doing a presentation. And then we will jump into Q&A.

And with that, I will turn it over to Jack and Bill.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Katerina, and, thanks for having us here today. We really appreciate that and always enjoy this conference. I'm Bill Peters. I'm the Chief Financial Officer of Amphasar Pharmaceuticals. I'm going to be jointly
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot